Published in
Elsevier, International Journal of Antimicrobial Agents, 3(49), p. 296-301
DOI: 10.1016/j.ijantimicag.2016.11.030
Links
Tools
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
Journal article published in 2017 by
Giuseppe Bruno,
Annalisa Saracino,
Claudia Fabrizio,
Luigia Scudeller 
,
Eugenio Milano,
Raffaele Dell'Acqua ,
Nicoletta Ladisa,
Massimo Fasano,
Salvatore Minniti,
Giovanni Buccoliero,
Alessandra Tartaglia,
Adele Giammario,
Michele Milella,
Gioacchino Angarano
,
Eugenio Milano,
Raffaele Dell'Acqua ,
Nicoletta Ladisa,
Massimo Fasano,
Salvatore Minniti,
Giovanni Buccoliero,
Alessandra Tartaglia,
Adele Giammario,
Michele Milella,
Gioacchino Angarano
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
The combination of sofosbuvir and simeprevir ± ribavirin (SOF + SMV ± RBV) for hepatitis C virus (HCV) treatment has been associated with high rates o…